Home » Suzhou Ark Biopharmaceutical patents new PDE4 inhibitors

To read the full story, subscribe or sign in.

Inflammatory

Suzhou Ark Biopharmaceutical patents new PDE4 inhibitors

April 29, 2025

Suzhou Ark Biopharmaceutical Co. Ltd. has disclosed phosphodiesterase PDE4 inhibitors.

BioWorld Science Inflammatory Patents